- Pharmacogenomic Assessment of Outcomes of Pemetrexed-Treated Patients with Adenocarcinoma of the Lung
-
Jung M, Lee CH, Park HS, Lee JH, Kang YA, Kim SK, Chang J, Kim DJ, Rha SY, Kim JH, Cho BC
- KMID: 2158218
- Yonsei Med J.
- 2013 Jul;54(4):854-864.
- doi: 10.3349/ymj.2013.54.4.854
PURPOSE: The main objective of this study was to evaluate the association between polymorphisms of the target genes of pemetrexed and clinical outcomes in non-small cell lung cancer (NSCLC) patients... -
- CITED
-
- Close
- SHARE
-
- Close
- EGFR Polymorphism as a Predictor of Clinical Outcome in Advanced Lung Cancer Patients Treated with EGFR-TKI
-
Jung M, Cho BC, Lee CH, Park HS, Kang YA, Kim SK, Chang J, Kim DJ, Rha SY, Kim JH, Lee JH
- KMID: 1414254
- Yonsei Med J.
- 2012 Nov;53(6):1128-1135.
- doi: 10.3349/ymj.2012.53.6.1128
PURPOSE: Mutations in the epidermal growth factor receptor (EGFR) have been confirmed as predictors of the efficacy of treatment with EGFR-tyrosine kinase inhibitors (TKIs). We investigated whether polymorphisms of the... -
- CITED
-
- Close
- SHARE
-
- Close
